实施龙头群链带动力提升行动。深化应用全区工业树产业林布局全景图，围绕链主企业深入开展重 点优势产业链补链强链延链专项行动。深入实施"人工智能+制造"行动，支持链主企业分类分级打造行 业数据集，开发垂直领域大模型，形成一批标志性智能产品和人工智能典型应用场景。支持链主龙头企 业牵头建设特色产业专业园区，吸引上下游企业集聚。 实施龙头产业链精准招商行动。建立产业链招商目标企业库，精准开展企业招商，全区每年新签补 链强链延链亿元以上项目超300个。支持链主企业以投资、合资、开放配套资源、采购订单等方式吸引 产业链上下游关键配套企业入桂投资设厂。支持链主企业加强与长江经济带、粤港澳大湾区和西部陆海 新通道沿线省份等区域的产业链合作，构建"海外资源+广西制造+全球市场"的跨境产业链供应链。 实施龙头产业链项目建设行动。建立产业链项目储备库，支持链主企业联合上下游配套企业、科研 院所共同谋划项目，重点储备产业链协同创新、智能化技术改造、绿色化转型、补链强链延链类项目。 鼓励链主企业牵头实施一批投资规模大、产业牵引力强、有利于塑造产业发展新局面的重大标志性工 程，力争实现每年新增"双百双新"产业项目100个以上。推动设备更 ...

Core Insights - The signing of seven key projects at the Foshan Yundonghai Pharmaceutical Health Industry Park marks a significant step in the development of the pharmaceutical and health industry in Foshan, with total investments exceeding 1 billion yuan [1][3][6]. Group 1: Event Overview - The high-quality development conference and project signing event was supported by the Guangdong Provincial Department of Industry and Information Technology and the Guangdong Provincial Drug Administration, and organized by the Foshan High-tech Industrial Development Zone Management Committee and Foshan Construction Development Group [2]. - This event signifies Foshan's commitment to cultivating new productive forces and building a biopharmaceutical industry cluster, injecting strong momentum into the high-quality development of the Greater Bay Area's pharmaceutical health industry [2]. Group 2: Project Details - The seven signed projects cover various cutting-edge fields, including biopharmaceuticals, new regenerative medical materials, high-end medical devices, and pharmaceutical packaging materials, with investment sizes ranging from 5 million to 800 million yuan [6]. - The Yundonghai Biological Science Industrial Park project, with a total investment of 800 million yuan, aims to build standard factories and high-tech public service platforms to meet the production needs of biopharmaceutical companies [6]. Group 3: Infrastructure and Services - The Guangdong Provincial Medical Device Quality Supervision and Inspection Institute's Foshan Laboratory was officially launched, serving as a core support for the park's service capabilities [10][12]. - The laboratory, as the only national-level medical device inspection institution in South China, covers four major fields and has the capacity for 338 standards and 2632 project parameters, significantly enhancing the speed of product market entry for local enterprises [11]. Group 4: Policy and Financial Support - The "Support Measures for the High-Quality Development of Yundonghai Pharmaceutical Health Industry Park" was released, offering multiple support measures for ten industry categories, with the highest funding amount reaching 15 million yuan [13]. - Foshan Jianfa Private Equity Fund and Huaxi Yuanyou Venture Capital Fund have reached a cooperation agreement with a total subscription scale exceeding 2.1 billion yuan, focusing on investments in biotechnology and health projects [14]. Group 5: Talent and Future Development - The Guangdong-Hong Kong-Macao Greater Bay Area (Foshan) Talent Service Workstation was inaugurated to provide one-stop services for policy consultation, entrepreneurial support, and talent introduction, enhancing the collaboration between industry, academia, and research [14]. - Foshan has over 3,000 medical and health institutions, a complete manufacturing industry chain, and a favorable business environment, aiming to attract more entrepreneurs to establish themselves in the Yundonghai area and jointly create a trillion-level pharmaceutical health industry cluster [14].